Q3FY17 Results : Natco Pharma Ltd.
Bhagyashree Vivarekar / 14 Feb 2017
The company reported PAT of Rs 194.84 crore, which represents a sequential QoQ increase of 194.23 per cent and a YoY increase of 434.54 per cent.
Natco Pharma Ltd. reported its results for the quarter ended December 31, 2016, earlier today.
The consolidated numbers were largely above expectations, with substantial jump in both topline and bottomline.
The company reported total sales of Rs 679.01 crore for Q3FY17, which represents a 45.13 per cent sequential increase and 135.69 per cent YoY increase.
Its operating profit (EBIT) for the quarter was Rs 246.5 crore and its EBIT margin stood at 36.3 per cent.
The company reported PAT of Rs 194.84 crore, which represents a sequential QoQ increase of 194.23 per cent and a YoY increase of 434.54 per cent.
The company has also declared second interim dividend of Rs 6 per share for face value of Rs 2 per share.
Natco Pharma Ltd is an Indian pharmaceutical company operating in four segments, viz. bulk chemicals, formulations, job work and others. The products of the company are segregated further into pharma and oncology (haemotology and solid tumors).
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.